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In recent years, resistance to antibiotics has become a great 
concern for microbiologists and physicians alike.[1‑7] In 
response to this broad‑spectrum resistance, antibiotics from 
the carbapenem class have been established as agents of last 
resort in treating these infections and are increasingly being 
used in recent decades as the only effective therapy. During 
the past decade, carbapenem resistance in Enterobacterales 
has emerged, and in recent years, widespread outbreaks of 
carbapenem‑resistant Enterobacterales (CREs) have been 
increasingly reported.[8] Since the breakpoints of carbapenem 
have been revised, decreased rates of susceptibility have 
been observed by the SENTRY Antimicrobial Surveillance 
Program from 2008 to 2012 in the United States.[9] According 
to laboratory‑based data collected over 3 years at a tertiary 
care in Pakistan, a change from 0% to 2% was noted in the 
resistance rates of CRE in 2010.[10]
Certain Gram‑negative bacilli acquire resistance to carbapenems 
by plasmid‑borne and easily transmissible carbapenemases,[8] 
and since timely control needs to be employed for CRE 
infections, it is imperative that such resistance mechanisms 
are detected as early as possible. The Clinical Laboratory 
Introduction: Carbapenem‑resistant Enterobacterales (CREs) are becoming increasingly popular as a cause of hospital‑acquired 
infections that are difficult to treat and are frequently reported as causes of outbreaks in various hospitals. Conventional culturing 
techniques take at least 2 days to report a case as carbapenem resistant, and it is therefore important to detect such resistance mechanisms 
as early as possible. Methods: This study aimed to compare the diagnostic performance of Carba NP, modified Hodge test (MHT), 
ethylenediaminetetraacetic acid (EDTA) disk synergy test (DST), and the modified carbapenem inactivation method (mCIM). This study 
was done at Microbiology Laboratory, Aga Khan University Hospital, Karachi. It was an observational study. Carba NP, MHT, EDTA 
DST, and the mCIM were performed on consecutive isolates of Enterobacterales. Sensitivity, specificity, and agreement between the 
four tests were calculated. Results: Of 207 Enterobacterales isolated, 127 were resistant to carbapenems. One hundred and fourteen of 
these were tested by a polymerase chain reaction, and the sensitivities of the Carba NP, MHT, EDTA DST, and the mCIM were found 
to be 94.34%, 75.47%, 79.25%, and 98.11%, respectively. Conclusions: Due to increased rates of carbapenem resistance, there is a 
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Standards Institute (CLSI) recommends to use such screening 
methods for the detection of CRE for epidemiological and 
infection control purposes.[11]
Although molecular tests are confirmatory, due to cost and 
equipment issues, various phenotypic methods have been 
developed for the detection of carbapenemases, which, despite 
their simplicity, take 18–24 h to yield results.[11,12]
The mCIM was included in the CLSI in 2017[13] and is a very 
simplistic method of carbapenemase detection employing 
the concept of carbapenem inactivation by immersing a 
carbapenem disk in a solution of suspected carbapenemase 
producers, and later using the same disk for susceptibility 
testing against a known sensitive strain. The Carba NP test is 
a rapid chromogenic test and there have been several studies 
to determine its diagnostic accuracy, and most have shown 
excellent results in terms of diagnostic accuracy.[14‑16] The 
modified Hodge test (MHT) and the ethylenediaminetetraacetic 
acid disk synergy test (EDTA DST) are some phenotypic tests 
that were previously used for carbapenemase detection in 
Enterobacterales.
In this study, we aim to compare the sensitivity and specificity 
and diagnostic accuracy of the modified Carbapenem 
inactivation method (mCIM), the Carba NP test, the MHT, and 
the EDTA EDTA DST for the detection of carbapenemases in 
Enterobacterales. In addition, other parameters like turnaround 
time and technical practicability were evaluated as well.
Methods
Setting
This study was carried out at the Aga Khan University 
Hospital (AKUH), Karachi, from June 2014 to January 
2016, nonprobability consecutive sampling technique was 
applied. Enterobacterales isolated from clinical samples such 
as urine, blood, pus, body fluids, and respiratory specimens 
were included. Duplicate samples from the same patient were 
excluded.
In addition, 114 previously saved Enterobacterales isolates 
were included. These isolates used to be part of a previous 
study performed at our institute[17] and were tested for NDM‑1, 
KPC, IMP, and VIM carbapenemase genes.
Identification
Conventional microbiological tests such as gram stain, growth 
on MacConkey agar, sulfide production, indole ring formation, 
motility, citrate utilization, urease production, and reaction on 
triple sugar iron were used for species‑level identification, and 
when in doubt, API® 20E (BioMérieux, Paris, France) was used 
for confirmation of identification.
Tests for susceptibility
Disk‑diffusion method: We performed disk diffusion for 
susceptibility testing of the Enterobacterales against carbapenems. 
As per the CLSI recommendations, a zone diameter of ≥23 mm 
was taken as sensitive and ≤19 mm as resistant.
Confirmation of carbapenem resistance: For isolates that were 
tested resistant on disk‑diffusion method, minimal inhibitory 
concentrations (MIC) were determined against meropenem using an 
automated system (VITEK 2® GN81) which works on the principle 
of broth microdilution. An MIC of ≥4 µg/ml was taken as resistant.
Testing by phenotypic methods
The organisms selected for the study were saved at –80°C and 
mCIM, Carba NP, MHT, and EDTA DST were performed in 
batches at an appropriate time later.
Carba NP test
This test was performed on the basis of following CLSI 
recommendations.[11] Briefly, a loop full of bacterial colonies 
was emulsified in cell lysis reagent, and to this added a solution 
containing imipenem and a pH‑based indicator (phenol red). 
A color change from red to yellow was taken as indicative of 
carbapenemase production.
Modified Hodge test
We performed the MHT as per CLSI guidelines.[11] Briefly, 
a carbapenem disk was placed in the center of a plate on 
which a lawn of Escherichia coli was made. Test organisms 
were streaked from the center to the periphery of the plate, a 
clover‑shaped indentation in the zone of inhibition formed by the 
growth of CRE at 18–24 h was considered positive [Figure 1].[11]
Ethylenediaminetetraacetic acid disk synergy test
We adjusted the test strains to the McFarland 0.5 standard 
and used them to make lawns on Mueller‑Hinton agar (MHA) 
plates. We then placed a 10‑µg IPM disk and a blank filter paper 
disk at a distance of 10 mm on each lawn and 10 µl of a 0.5 M 
EDTA solution was added to the blank disk. After overnight 
incubation, the presence of even a small synergistic inhibition 
zone was interpreted as positive [Figure 2].[12]
Modified carbapenem inactivation method
mCIM was performed as per the CLSI guidelines. Briefly, 18–24 h 
growths of test organisms were emulsified in Trypticase Soy 
Broth, a meropenem disk was added and incubated for 4 h. This 
Figure 1: Modified Hodge test. Block arrow – carbapenemase 
nonproducer, thin arrow – carbapenemase producer
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disk was placed on a lawn of 0.5 Mc Farland ATCC E. coli 25922 
on MHA and incubated for 18–24 h. After this time, zone sizes 
around the meropenem disks were interpreted as carbapenemase 
positive or negative as per the CLSI recommendations.
Molecular methods
Molecularly tested isolates were borrowed from a previous 
study as mentioned earlier. In that study, presence of gene 
for carbapenemases class A KPC enzymes and class B 
metallo‑beta‑lactamase (blaNDM‑1, blaIMP‑1, and blaVIM‑1) was 
detected using polymerase chain reaction (PCR). Different 
primers were used for the above‑mentioned genes, blaNDM‑1 
genes were detected through conventional PCR, using the 
following primer sequence: F GGG CAG TCG CTT CCA ACG 
GT; R GTA GTG CTC AGT GTC GGC AT. Deoxyribonucleic 
acid (DNA) was extracted by Qiagen DNA extraction 
kit (Qiagen, CA, USA). A 475 bp product was amplified by 
NDM primers and visualized on 3% agarose gel.
Statistical analysis
The sensitivity, specificity, positive likelihood ratio, negative 
likelihood ratio, and diagnostic accuracy for Carba NP, 
MHT, EDTA DST, mCIM, and Vitek2 MIC were calculated 
using molecular method of carbapenemase gene detection. 
Agreement between the methods was also checked, and kappa 
scores were calculated. Finally, IBM SPSS statistics (IBM 
Corp. Released 2013. IBM SPSS Statistics for Windows, 
Version 22.0. Armonk, New York: IBM Corp., United States 
of America), was utilized for data entry and analysis.
Results
At the end of the study duration, there were a total of 207 
Enterobacterales. Details of susceptibility and tests for 
carbapenemase detection are shown in Figure 3. Klebsiella 
species and E. coli were the most common organisms that were 
isolated. Figures 4 and 5 describe the identification and sources 
of these isolates in relation to their carbapenem susceptibility 
as per the defined standards, respectively.
The results of all the performed tests are shown in Table 1.
As per our reference (MIC) standard, 127 Enterobacterales 
were found to be resistant to carbapenems. Of these, 114 
were also tested for the presence of bla‑NDM‑1, the results 
are shown in Table 2.
Eight carbapenem‑resistant isolates were negative for 
bla‑NDM‑1, thus they were also tested for IMP, KPC, and 
VIM, which were not found in these isolates.
We tested all of these (207) isolates for carbapenemase 
production by using four phenotypic methods, i.e., mCIM, 
Carba NP, MHT, and EDTA DST. However, the calculated 
sensitivity, specificity, positive and negative likelihood 
ratio, and diagnostic accuracy were possible in only 114 
isolates tested by carbapenemase gene, as shown in Table 2. 
A receiver operating characteristic curve was made to assess 
the diagnostic accuracy [Figure 6]. Table 3 shows agreement 
between the four phenotypic tests that were performed.
The Carba NP had a substantial agreement with the MHT, 
EDTA DST, and mCIM, while there was moderate agreement 




























































Figure 3: Schematic representation of results
Figure 2: Ethylenediaminetetraacetic acid disk synergy test. 
1 – carbapenemase producer, 2 – carbapenemase nonproducer
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of carbapenemase detection with other previously known 
phenotypic methods of carbapenemase detection and has 
confirmed the positive results with PCR.
The mCIM has been shown previously to be highly sensitive 
and specific,[18,19] and the current study also demonstrates it to 
be a highly sensitive test. Similarly, our study results validate 
the previously reported high sensitivity[14‑16] of Carba NP 
method. The other two methods (MHT, EDTA DST) showed 
comparatively lower sensitivities.
The Carba NP and mCIM had very good diagnostic accuracies 
of 89% and 91%, respectively,[19] and there was substantial 
agreement between the two. A limitation regarding the 
specificity of the four phenotypic tests found in this study is 
that a very small number of isolates were PCR negative, even 
though they were carbenem resistant according to their MICs. 
The low specificity of all the tests may therefore be attributable 
to the small number of NDM‑1 negative isolates, and not a 
true reflection of the diagnostic accuracy.
If we compare the turnaround time of four tests, the Carba NP is 
the most rapid as it takes 2 h for performance and obtaining results. 
Although preexisting phenotypic methods of carbapenemase 
detection such as the MHT and EDTA DST are simpler to perform 
and perhaps more cost‑effective than the Carba NP, they have 
longer turnaround times and are not as accurate.[12,17,20] The mCIM 
has good diagnostic accuracy, but like the MHT and EDTA DST, 
it takes 18–24 h for the results to be read, and thus, the Carba NP 
seems like an attractive option for microbiologists and clinicians 
considering its shorter turnaround time.
On the other hand, the Carba NP is the most meticulous, while 
the mCIM, MHT, and EDTA DST are considerably simpler to 
perform. While the MHT, EDTA DST, and mCIM all involved 
steps like making lawns of standard solutions of organisms 
and placing disks and/or making streaks, the Carba NP needed 
careful measurement by weight of imipenem powder, adjusting 
the pH of solutions, and cautious pipetting to mention a few. It 
may, therefore, need staff well trained in procedures involving 
pipetting and media preparation, and laboratories must keep 
in mind all these factors when deciding on which test to select 
as a screening tool.
Increase in carbapenem resistance has become a major 
problem both worldwide[7] and locally. Data from AKUH, 
Table 2: Sensitivity, specificity, positive and negative likelihood ratios, and diagnostic accuracy for Carba NP test, 
modified Hodge test, EDTA disk synergy test, modified carbapenem inactivation method using NDM‑1 Polymerase chain 
reaction as a gold standard






Carba NP 94.34 (88.2‑97.38) 25 (7.15‑59.07) 1.258 (0.841‑1.882) 0.226 (0.054‑0.946) 89.4
EDTA DST 79.25 (70.57‑85.888) 25 (7.15‑59.07) 1.057 (0.7‑1.595) 0.830 (0.236‑2.917) 75.4
MHT 75.47 (66.49‑82.68) 37.50 (13.68‑69.43) 1.208 (0.698‑2.088) 0.654 (0.252‑1.7) 72.4
mCIM 98.11 (93.38‑99.48) 00 (0.00‑32.44) 0.981 (0.956‑1.007) ‑ 91.22
CI: Confidence interval, DST: Disk synergy test, mCIM: Modified carbapenem inactivation method, MHT: Modified Hodge Test, 
EDTA: Ethylenediaminetetraacetic acid
dIscussIon
To the best of our knowledge, this is the first study from 
Pakistan that has compared modern phenotypic techniques 
Table 1: Results of Carba NP test, modified Hodge 
test, EDTA disk synergy test, and modified carbapenem 
inactivation method for those isolates which were also 
tested for blaNDM‑1















DST: Disk synergy test, mCIM: Modified carbapenem inactivation method, 
PCR: Polymerase chain reaction, MHT: Modified Hodge test, NDM: New 
Delhi Metallo‑β‑Lactamase, EDTA: Ethylenediaminetetraacetic acid
Figure 4: Carbapenem resistance and susceptible Enterobacterales
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Karachi, Pakistan,[21] show that carbapenem resistance in 
Enterobacterales rose from an average of 9.6% in 2013–13.5% 
in 2016, emphasizing the need for the implementation of rapid 
tests for carbapenemase detection in the laboratory.
In our study, most of the isolates were identified as 
E. coli (51.2%), followed by Klebsiella pneumoniae (41.5%). 
However, of the resistant isolates, the breakup was 59% for 
Klebsiella and 32% for E. coli. This correlates with previous 
studies, in which most resistant organisms were identified as 
Klebsiella species.[20,22‑24] Klebsiella species are known to be 
the most common carbapenemase‑producing Enterobacterales 
in the health‑care settings and have become a significant cause 
of morbidity and mortality in the admitted patient.[25]
This study has some limitations. First, the sample size was low. 
Second, only a subset of carbapenem‑resistant isolates was 
tested for commonly found resistance genes, and therefore, 
diagnostic accuracy parameters, specificity to be more exact, 
gave unexpected results. Although MIC is considered to be 
confirmatory for the purpose of reporting resistance,[11] the 
presence of carbapenemase cannot be attributed to MIC 
alone, and a genotypic analysis is necessary to imply that an 
organism harbors carbapenemase as the resistance mechanism, 
which is why diagnostic accuracy could not be calculated 
using MIC as a gold standard. Third, the result of this study 
cannot be generalized to carbapenemase enzymes other than 
NDM‑1 metallo‑beta‑lactamase group as all PCR‑proven 
isolates tested for these phenotypic methods belonged to this 
carbapenemase group.
conclusIons
Due to increased rates of carbapenem resistance, there is a 
need to employ mechanisms in hospitals that can identify 
such organisms as early as possible, both from clinical and 
epidemiological standpoint. The Carba NP test is a rapid, 
cost–effective, and reliable method that can be safely used for 
the screening of CREs in case of outbreak or infection control 
in the hospital setting.
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